NCT03239184

Bioinformation Therapy for Pancreatic Cancer

Combination of Cancer Ablation and Life Information Rehabilitation Therapy for Unresectable Pancreatic Cancer

• Status: Completed
• Phase: Phase 2 / Phase 3
• Study type: Interventional
• Enrollment: 120 (actual)
• Sponsor: Fuda Cancer Hospital, Guangzhou · Academic / Other
• Sex: All
• Age: 30 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

The aim of this study is the synergistic effect of cancer ablation and life information rehabilitation therapy on unresectable pancreatic cancer.

Detailed description

By enrolling patients with unresectable pancreatic cancer adapted to enrolled criteria, this study will document for the first time the synergistic effect of cancer ablation and life information rehabilitation therapy. The efficacy will be evaluated according to local relief degree, progress free survival (PFS) and overall survival (OS).

Conditions

• Unresectable Pancreatic Cancer

Interventions

Type	Name	Description
DEVICE	Cancer ablation	Tumors bigger than 2 cm are fit for ablation therapy, percutaneously under CT scan or ultrasound
DRUG	Life information rehabilitation therapy	Each treatment: one bottle solution each day, consecutive 3 months, oral administration

Timeline

• Start date: 2017-09-01
• Primary completion: 2018-09-01
• Completion: 2018-09-01
• First posted: 2017-08-03
• Last updated: 2019-01-25

Locations

1 site across 1 country: China